Cargando…
Amikacin pharmacokinetic/pharmacodynamic in intensive care unit: a prospective database
BACKGROUND: Aminoglycosides have a concentration-dependent therapeutic effect when peak serum concentration (C(max)) reaches eight to tenfold the minimal inhibitory concentration (MIC). With an amikacin MIC of 8 mg/L, the C(max) should be 64–80 mg/L. This objective is based on clinical breakpoints a...
Autores principales: | Logre, Elsa, Enser, Maya, Tanaka, Sébastien, Dubert, Marie, Claudinon, Aurore, Grall, Nathalie, Mentec, Hervé, Montravers, Philippe, Pajot, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276966/ https://www.ncbi.nlm.nih.gov/pubmed/32514769 http://dx.doi.org/10.1186/s13613-020-00685-5 |
Ejemplares similares
-
Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU
por: Contou, Damien, et al.
Publicado: (2020) -
Thrombotic and hemorrhagic events in critically ill COVID-19 patients: a French monocenter retrospective study
por: Fraissé, Megan, et al.
Publicado: (2020) -
Pulmonary embolism or thrombosis in ARDS COVID-19 patients: A French monocenter retrospective study
por: Contou, Damien, et al.
Publicado: (2020) -
Evaluation of Amikacin Pharmacokinetics and Pharmacodynamics for Optimal Initial Dosing Regimen
por: Kato, Hideo, et al.
Publicado: (2017) -
Eosinophilia in critically ill COVID-19 patients: a French monocenter retrospective study
por: Fraissé, Megan, et al.
Publicado: (2020)